EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹3,449 Cr | ₹2,737 Cr | ₹2,523 Cr | ₹2,942 Cr | ₹3,100 Cr |
What is the latest Total Non-Current Assets ratio of EMCURE PHARMACEUTICALS ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹3,449 Cr |
Mar2023 | ₹2,737 Cr |
Mar2022 | ₹2,523 Cr |
Mar2021 | ₹2,942 Cr |
Mar2020 | ₹3,100 Cr |
How is Total Non-Current Assets of EMCURE PHARMACEUTICALS Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹3,449 Cr | 26.01 | |
Mar2023 | ₹2,737 Cr | 8.49 | |
Mar2022 | ₹2,523 Cr | -14.22 | |
Mar2021 | ₹2,942 Cr | -5.11 | |
Mar2020 | ₹3,100 Cr | - |
Compare Total Non-Current Assets of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹24,570.6 Cr | 4.3% | -5.9% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 4.3% |
-5.9% |
|
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses